Biomarkers for chronic transplant dysfunction

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007200, C436S518000

Reexamination Certificate

active

07998687

ABSTRACT:
The invention relates to the analysis and identification of genes that are modulated in transplant rejection. This alteration of gene expression provides a molecular signature to accurately detect transplant rejection.

REFERENCES:
patent: 2003/0104371 (2003-06-01), Strom et al.
patent: 99/15700 (1999-04-01), None
patent: 03/062467 (2003-07-01), None
patent: 2004/018710 (2004-03-01), None
patent: 2004/074815 (2004-09-01), None
Racusen L.C. et al., “The banff 97 working classification of renal allograft pathology”, Kidney International, vol. 55, pp. 713-723, (1999).
Nankivell B.J. et al., “The natural history of chronic allograft nephropathy”, The New England Journal of Medicine, vol. 349, No. 24, pp. 2326-2333, (2003).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Biomarkers for chronic transplant dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for chronic transplant dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for chronic transplant dysfunction will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2765568

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.